Why a Single Entry Point for Nanopharmaceutical Innovation?
To introduce this new enterprise to potential customers, we sat down with PHOENIX-OITB gGmbH CEO Dr. Nazende Günday-Türeli to discuss…
To introduce this new enterprise to potential customers, we sat down with PHOENIX-OITB gGmbH CEO Dr. Nazende Günday-Türeli to discuss…